Introduction and Clinical Pathology
Amyotrophic lateral sclerosis (ALS) is a prototypic, agedependent neurodegenerative disorder. It typically afflicts individuals in middle adult life, leading to paralysis and death within 3 to 5 years (Williams and Windebank, 1991) . The disease usually begins asymmetrically and distally in one limb, most commonly the leg, and then appears to spread within the neuraxis to involve contiguous groups of motor neurons. Pathologically, ALS is distinguished by atrophy and death of the affected neurons, with dissolution of both cytoplasm and nuclei. The motor neuron death process appears to be cell autonomous; autopsy studies reveal no evidence that other cell types participate in killing motor neurons. Many affected neurons demonstrate evidence of cytoskeletal pathology in the form of accumulations of neurofllaments, both within the neuronal cell body and in axons. Aggregates of ubiquitinated, unidentified proteins are also seen, as is subtle proliferation of glial cells (Leigh and Swash, 1991) . Recent investigations have implicated oxidative cytotoxicity in the pathogenesis of a familial form of ALS (FALS). This review considers the evidence that this disease arises from oxidative and excitotoxic injury to critical subcellular targets in motor neurons and summarizes current hypotheses concerning the mechanism of motor neuron death in ALS.
Possible Causes of Motor Neuron Disease
As with any neurodegenerative disorder, etiologic hypotheses in ALS must explain three essential aspects of the disease: the mechanisms and pathways leading to cell death, the selectivity of the process for the affected neurons, and the onset in adulthood. While many hypotheses have been advanced to explain the pathogenesis of ALS, as reviewed by Rowland (1991) , few have adequately explained each of these aspects. The motor neuron selectivity of poliovirus has prompted the theory that ALS might represent an atypical polioviral infection; to date, traditional culturing methods and in situ RNA hybridization have failed to detect poliovirus in ALS cerebrospinal fluid and brain specimens. The possibility that ALS might be a form of slow viral infection has not been supported by long-term studies of inoculation of ALS brain tissues into nonhuman primates. Because they may induce clinical paralysis and motor nerve pathology in some experimental animals, lead, aluminum, and other metallotoxins have also been implicated. Thus far, however, no convincing clinical or necropsy data support this hypothesis in conventional ALS. Both spinal and corticospinal motor neuron degeneration can be induced as autoimmune diseases. This and other observations have occasioned the hypotheReview sis that ALS may arise on an autoimmune basis. While sera of many patients with sporadic ALS possess autoantibodies that react with constituents of the distal motor terminal, including voltage-dependent calcium channels, it has not been demonstrated that these are causal. Moreover, patients with ALS show no benefit from immunosuppressive therapy, although this does not rigorously preclude an autoimmune etiology. Several lines of inquiry indicate that toxicity from excitatory neurotransmitters such as glutamate may be one factor in the pathobiology of ALS. Brain tissue levels of glutamate are depressed (e.g., Perry et al., 1987) , while cerebrospinal fluid glutamate and aspartate levels may be elevated both in sporadic human ALS patients (Rothstein et al., 1990; cf. Perry et al., 1990) and in canine motor neuron disease (Tsai et al., 1993) . Additionally, glutamate transport is diminished in synaptosomal preparations from ALS brains (Rothstein et al., 1992) . Recently, genetic studies have delineated two proteins that are defective in some cases of ALS: superoxide dismutase (SOD) and neurofilament heavy chains. As argued below, several lines of investigation prompted in part by these genetic findings suggest the hypothesis that the motor neuron death process in ALS reflects a complex interplay among oxidative injury, excitotoxic stimulation of the motor neuron, and dysfunction of mitochondria and critical proteins such as neurofilaments.
SOD1 and ALS
Two forms of ALS are inherited. The predominant form, transmitted as an autosomal dominant trait, is an adultonset disease that is clinically and pathologically indistinguishable from sporadic ALS. About 10%-15% of all ALS cases fall within this category. In recent years, there has also been recognized a rare, recessively inherited childhood-onset form of ALS associated with very long survival (Ben Hamida et al., 1990) . The clinical and pathological similarity between the dominantly inherited and sporadic forms of ALS prompted a multicenter effort to identify one or more ALS genes on the premise that insights into the inherited disease might illuminate the pathogenesis of sporadic ALS. In 1991, an ALS locus was identified on human chromosome 21q, although only a fraction of all ALS families were linked to this region (Siddique et al., 1991) . In 1993, a gene within this region encoding the protein cytosolic copper-zinc SOD (SOD1) was found to be mutated in several ALS families (Rosen et al., 1993) .
At present, more than 20 missense mutations in SOD1 have been reported exclusively in FALS patients. The product of SOD1 is a metalloenzyme of 153 amino acids (Fridovich, 1986) . It is thought to be expressed in all eukaryotic cells and is one of a family of three SOD enzymes, which also include manganese-dependent mitochondrial SOD (SOD2) and copper-zinc extracellular SOD (SOD3).
SOD1 is encoded by five exons and forms a globular protein that functions as a homodimer (Levanon et ai., 1985 of this enzyme is believed to be the detoxification or dism utation of the superoxide anion to form hydrogen peroxide ( Figure 1 ). This, in turn, is detoxified by either glutathione peroxidase or catalase to form water. As shown in Figure  1 , under normal circumstances, superoxide anion can also react with nitric oxide to form peroxynitrite (Koppenol et al., 1992) . One major implication of this biochemical profile of SOD1 reactivity is that FALS may be a consequence of disturbed free radical homeostasis and cytotoxicity by reactive oxygen species.
Over the last year, several studies have begun to define the effects of the FALS mutations on SOD1 function, although many critical questions remain unanswered. It is now clear that the mutations reduce total cellular activity of the enzyme by 25% -50% , as analyzed in red blood cells, lymphoblastoid cell lines, and brain Bowling et al., 1993; Robberecht et al., 1994) . Analysis of cytoplasmic SOD activity in both lymphoid and COS cells has established that the loss of activity does not arise from a dominant negative interaction of mutant and wildtype protein in SOD1 heterodimers. Rather, the loss of function is due to diminished stability of the mutant protein per se; depending on the specific mutations, the half-lives of the mutant proteins are reduced by 30o-75% (Borchelt et al., 1994) .
These observations present a conundrum. Most diseases arising from inactivity of a protein or from so-called loss of function are recessive, as most proteins exist in sufficient abundance that their levels must be significantly reduced (typically, <5o--10% of normal) before a cellular phenotype results. On the other hand, dominantly inherited diseases, like FALS, are usually thought to arise because a single mutant allele produces a mutant protein with a novel property that may be injurious to the cell. In the context of FALS, the fundamental question is whether the motor neuron degeneration arises purely from loss of SOD1 activity, which clearly occurs for some of the mutations, or from gain of a novel adverse function. This has an important therapeutic ramification: if the disease is a consequence of diminished function of the SOD1 protein (i.e., decreased dismutation of the superoxide anion or diminished binding of copper and zinc), therapies that augment levels of SOD1 activity may be beneficial in FALS (Table 1) .
Firm conclusions are not yet possible, but two somewhat conflicting lines of investigation are relevant. It has recently been shown in chronic, organotypic spinal cord cultures that partial reduction of activity of SOD1 by chronic application of SOD1 antisense oligonucleotides triggers neuronal death, including fulminant motor neuron death. Strikingly, the death process, which is reversed by agents that enhance intracellular antioxidant defenses (e.g., N-acetylcysteine), is apoptotic (Rothstein et al., 1994) . Similar results have been observed in cultures of PC12 cells (Troy and Shelanski, 1994) . Because they are chronically incubated in supraphysiologic levels of oxygen, it is probable that these cultured neurons are under chronic oxidative stress and therefore not fully representative of neurons in vivo. Nonetheless, a cautious interpretation of these experiments is that, under certain conditions, diminished levels of SOD1 activity jeopardize survival of neurons.
By contrast with the foregoing experiments, compelling data from at least three laboratories indicate that the FALS mutations in SOD1 may act through cytotoxic, possibly novel functions Price et al., 1994; Ripps et al., 1995) . As demonstrated by Gurney et al. (1994) , mice that overexpress high levels of mutant SOD1 protein develop a denervating, paralytic process that resembles ALS both clinically and pathologically. As the paralysis develops in these animals, dendritic processes in motor neurons show microvacuolization, interpreted to result from defects in rough endoplasmic reticulum and mitochondria . Some mitochondria show extensive and unusual separation of the inner and outer mitochondrial membranes. Because the levels of total or aggregate SOD1 activity in these animals are greater than normal, it is difficult to argue that the disease arises from loss of function, unless there is some type of highly focal subcellular loss of function.The possibility that the high levels of SOD1 activity in the animals trigger the neuronal degeneration is unlikely, as mice overexpressing normal SOD1 to a similar extent do not develop motor neuron disease. Thus, a plausible interpretation of the motor neuron disease in these mice is that the mutant SOD1 molecule is in some way cytotoxic.
Further support for the argument that the SOD1 mutations kill motor neurons via gain of a novel function rather than loss of function is the absence, to date, of clear null mutations in SOD1 in FALS patients. If haploinsufficiency (50% reduction in activity from loss of'the product:of one allele) causes the disease, one would anticipate finding some mutations that prevent protein expression from the (Park and Horvitz, 1986) .
mutant allele (e.g., by introducing premature stop codons or deletions of the gene). Such null mutants are conspicuously absent. One candidate for a null SOD1 mutation, a 2 bp deletion, is predicted to introduce a premature stop codon that would truncate 23 amino acids from the 3' end of the molecule (Pramatarova et al., 1994) . However, it is not yet clear whether this is a true null mutation, These considerations suggest it is unlikely that FALS is caused solely, i f at all, by a decrease in SOD1 activity. The central question then is what are the mechanisms of cytotoxicity of the mutant SOD1 molecule? Is it possible, as recently suggested (Tsuda et al., 1994) , that different mutations may act via different mechanisms? While experimental data concerning this point are sparse, several possibilities are noted (see Table 1 ). First, the mutant enzyme may be so unstable that it precipitates to form toxic cytoplasmic aggregates. Second, the mutant SOD1 molecule may have an altered substrate affinity that leads to high levels of toxic reaction products. For example, it has been proposed that the mutant SOD1 molecule may have an enhanced affinity for peroxynitrite and, in consequence, produce elevated levels of nitronium ions that, in turn, catalyze nitration of tyrosines on proteins such as neurofilaments and tyrosine kinase receptors (Beckman et al., 1993) . Third, if the stability of the mutant enzyme is reduced, there may be subnormal copper or zinc buffering by the enzyme and resulting neurotoxicity from one or both of these metals. It is well established that copper is a neurotoxin (Scheinberg, 1988) ; indeed, as a transition metal, it can participate in several types of oxidative biochemical reactions. Similarly, zinc also has the potential to be neurotoxic (Koh and Choi, 1988; Ebadi et al., 1990) . Concomitantly with these abnormal properties, the mutant SOD1 protein may also be cytotoxic because its reduced ability to detoxify superoxide anion will result in increased levels of this anion and, secondarily, in increased levels of peroxynitrate. The latter may be toxic through its ability to nitrate protein-tyrosine groups or its nonenzymatic decomposition to produce nitrogen dioxygen and hydroxyl radical.
Neurofilaments and ALS
Another central question is why mutations in an enzyme that is ubiquitously expressed cause an illness so exquisitely specific to motor neurons, at least as gauged on clinical grounds. While no clear answer is available, it is likely that some property of the motor neuron confers a particular susceptibility to the effects of the SOD1 defects. Like all neurons, the motor neuron is a postmitotic, highly differentiated cell with a distinctive, polarized cellular anatomy. Unlike most neurons, motor neurons tend to be very large, with extremely high ratios of axonal length to cell width (up to 10,000:1 in the case of a lumbosacrat motor neuron in an adult). This suggests that particular constituents of the motor neuron required to maintain this distinctive morphology, such as cytoskeletal proteins, may be essential for long-term motor neuron viability and may be critical targets for injury, perhaps by reactive oxygen species in FALS. Indeed, some authors report an early finding in sporadic ALS and FALS of neurofilamentous accumulations in cell bodies and proximal axons (Hirano, 1991) . In this context, it is striking that two different mutations in the heavy chain of neurofilament have recently been associated with ALS in three patients . Because these mutations were not detected in more than 300 DNA samples from normal controls, they are unlikely to be polymorphisms. It remains to be established whether these neurofilament mutations will be present in large series of either sporadic ALS or FALS patients. However, it is pertinent that transgenic mice overexpressing either normal or mutant neurofilaments develop a motor neuron disease phenotype (CSt~ et al., 1993; Xu et al., 1993) . Moreover, mice that express a point mutation in the light neurofilament subunit even more fully reproduce aspects of human ALS pathology . Further, animals intoxicated with the agent 13-l~-imino-diproprionitrile develop severe neurofibrillary pathology, particularly in the proximal axon, which disrupts axonal transport and thereby impairs motor neuron function (reviewed by Griffin et al., 1982) . Together, these findings in humans In the normal neuron, superoxide is detoxified by SOD1 to hydrogen peroxide that is converted to water by catalase and glutathione. The mechanism whereby mutant SOD1 is toxic is not understood. It may be toxic because it is unstable and precipitates within the cytoplasm and axoplasm; alternatively, the mutant protein may fail to buffer the neurotoxic metals zinc and copper. Mutant SOD1 may also be cytotoxic because its activity is reduced; in this case, increased levels of superoxide anion enhance formation of peroxynitrite that may induce oxidative injury by itself or through either the formation of hydroxyl radicals or nitration of tyrosine residues on critical motor neuron proteins. One such set of protein targets are the neurofilaments (NF) whose injury (by mutation, oxidative degradation, or extrinsic insults) results in formation of fibrillary spheroids that may disrupt axonal transport. In this model, excitatory neurotransmitters such as glutamate augment any of these forms of toxicity by increasing levels of free cytosolic calcium and thereby enhancing formation of superoxide and nitric oxide and impairing mitochondrial function. This process of neuronal injury may be self-sustaining. Free radicals may compromise the structural integrity of mitochondria and the neuronal membrane. This leads, respectively, to enhanced mitochondrial release of hydroxyl radicals and other reactive oxygen species and to increased fluxes of calcium into the neuron from the extracellular space. Moreover, because it is highly lipophilic, nitric oxide can diffuse from one cell to another, thereby triggering cell-to-cell spread of the pathologic process (dashed arrow). Conceivably, extrinsic factors such as exogenous toxins might also initiate this cascade of events.
and experimental animals underscore the importance of cytoskeletal protein function for motor neuron viability.
Excitotoxicity and Motor Neuron Selectivity
Both in the mouse models and in human ALS, it is likely that an additional factor beyond the complex cellular morphology and cytoskeletal function is a critical determinant of susceptibility to ALS. After all, the dorsal root ganglia of sensory neurons have similarly exaggerated axonal lengths but do not degenerate in ALS. An important feature distinguishing motor neurons from the dorsal root ganglia neurons is the presence of excitatory synapses on the former. As stated above, data have implicated toxicity from normal excitatory inputs in the pathogenesis of ALS. There are several ways in which such glutamatergic excitatory synaptic input enhancesthe sensitivityof the motor neuron to free radical injury. The central element in neuronal excitotoxcity is an elevation of cytosolic free calcium levels that, in turn, activates calcium-dependent enzymes, including proteases and enzymes such as xanthine oxidase and phospholipase A2 (which may elevate levels of superoxide anion) or nitric oxide synthase (which forms nitric oxide) (Coyle and Puttfarcken, 1993) . Indeed, the motor neuron may be particularly sensitive to increases in cytosolic calcium levels because, by comparison with other types of neurons, it is relatively poor in some calciumbinding proteins such as calbinden D-28k and parvalbumin (Ince et al., 1993) . At least in cultured hippocampal neurons, concomitant elevation of nitric oxide and superoxide anion is a sine qua non of excitotoxicity, presumably through their combination to form peroxynitrite (Dawson et al., 1993; see also Choi, 1993) . Thus, as illustrated in Figure 2 , superoxide anion may be an essential element in the pathway to excitotoxic cellular injury.
Summary Model of Motor Neuron Death Process in ALS
Figure 2 attempts to integrate within a single model the relationship among mutations in SOD1, excitotoxic stimulation, mitochondrial function, and the integrity of the cytoskeleton. It offers an overview of possible mechanisms of pathogenesis (oxidative injury to or mutations in critical proteins such as neurofilaments, failure of axonal transport) and a possible basis for motor neuron selectivity (complex anatomy of the motor neuron and excitotoxicity). The model does not inherently provide an explanation for the timing of onset of the disease, although one may speculate that age-dependent factors modify the scheme. For example, the normal accumulation of age-dependent oxidative injury may determine the time at which a superimposed oxidative challenge suffices to trigger irreversible pathology in the motor neuron. It is also possible that agerelated decrements in mitochondrial function progressively reduce ATP production until motor neuron viability is marginal; in this setting, the otherwise inocuous stimuli described in Figure 2 might render the motor neuron nonviable.
Three features of this model are noted. First, the processes it depicts are potentially self-reinforcing. For example, if superoxide anion or other reactive radicals impair mitochondrial function, these organelles may release reactive species that, in turn, injure other cellular structures as well as other mitochondria. Indeed, elevation of cytosolic calcium can, by itself, trigger hydroxyl radical release from mitochondria (Dykens, 1993) . Further, evidence suggests that as mitochondrial function deteriorates, the potency of excitotoxic stimuli increases . The possibility that mitochondrial pathology may be an element early in the pathogenesis of ALS is predicated on the observation (discussed above) that vacuolar distortion of mitochondria occurs early in the course of the motor neuron degeneration in the SOD1 transgenic mice. While there is little microscopic evidence for specific pathology of mitochondria in ALS in humans, activity of mitochondrial complex I activity is increased in brains of patients with FALS (Bowling et al., 1993) . The processes depicted in Figure 2 are also self-sustaining simply because the progression of cell death is likely to entail loss of membrane integrity and increased cytosolic free calcium levels that may, in turn, signal further cytotoxic activity. A second feature of this model is that it allows for cell-to-cell spread of the pathologic process, an aspect strongly suggested by the clinical pattern of disease progression. Thus, the model attributes a central role to nitric oxide in the development of neuronal toxicity. This highly lipophilic substance is documented in vitro to pass through membranes and cells as readily as oxygen. Once generated in injured motor neurons, it may diffuse into neighboring cells wherein it may interact with superoxide to trigger an analogous series of self-sustaining cytotoxic events (Dawson et al., 1993) . A third point inherent within this model is a role for extrinsic cellular phenomena to modulate the process. Extracellular factors that stimulate oxidative stress, such as exogenous toxins or perhaps trauma to the motor neuron or spinal cord, may trigger or accelerate this sequence of pathological reactions.
Oxidative Toxicity in Motor Neuron Disease
The model outlined in Figure 2 does not depend uniquely on oxidative injury as a trigger of the pathologic process. On the other hand, the fact that SOD1 mutations can cause FALS raises this hypothesis and predicts there may be heightened oxidative injury in neural tissues of ALS patients. Consistent evidence for this does not yet exist. An early screen for markers of free radical injury in ALS cerebrospinal fluid was unrevealing (Mitchell et al., 1987) . By contrast, a recent study of brains of sporadic ALS patients documented elevated levels ot carbonyl proteins, indicating oxidative protein damage (Bowling et al., 1993) . Analyses now in progress of other markers of oxidative injury will be pivotal in evaluating the role of oxidative stress in the motor neuron death process in ALS.
Concluding Questions and Future Directions
These investigations of sporadic ALS and of FALS highlight the importance of several possible determinants of motor neuron viability, including free radical homeostasis, critical motor neuron organelles and proteins, and excitatory neural inputs on the motor neuron. Exactly how important each of these factors is should become apparent from studies addressing several critical questions. One is whether, in any form of motor neuron disease, there is unequivocal oxidative injury within the nervous system, beyond that which accumulates during normal aging. Quite simply, the question remains: is ALS a free radical disease? If FALS is caused by a novel function of the mutant SOD1 protein, what is the function? Further, what other genes are defective in FALS cases not arising from SOD1 mutations? Will these also implicate oxidative pathology? Will the pathogenetic mechanisms delineated in FALS prove relevant to understanding the more common sporadic forms of the disease? Is the motor neuron death process in ALS apoptotic or necrotic? If it is apoptotic, can it be slowed with antiapoptotic agents such as Bcl-2 or cysteine protease inhibitors? One hopes that the insights gleaned through these questions will be pertinent not only to ALS but also to other neurodegenerative diseases. Most importantly, one anticipates that such studies will lead ultimately to effective strategies for slowing or reversing the death of motor neurons in ALS patients.
